Skip to main content

Table 4 Changes of medication from baseline to 24 months follow-up among patients with improvements of the HbA1c level of more than 0.2%, by group

From: Patient-centered communication and shared decision making to reduce HbA1c levels of patients with poorly controlled type 2 diabetes mellitus - results of the cluster-randomized controlled DEBATE trial

  Group Total
Intervention Control
Diabetes Medication Diabetes Medication Diabetes Medication
Less No change More Less No change More Less No change More
No improvement Numbers 38 156 71 40 116 68 78 272 139
Percentages 14% 59% 27% 18% 52% 30% 16% 56% 28%
Improvement Numbers 14 35 24 8 47 26 22 82 50
Percentages 19% 48% 33% 10% 58% 32% 14% 53% 32%